Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
ATRC > SEC Filings for ATRC > Form 8-K on 16-Jan-2013All Recent SEC Filings

Show all filings for ATRICURE, INC.

Form 8-K for ATRICURE, INC.


16-Jan-2013

Entry into a Material Definitive Agreement, Financial Statements and Exhibits


Item 1.01 Entry Into a Material Definitive Agreement.

On January 16, 2013, AtriCure, Inc. ("AtriCure" or the "Company") entered into a purchase agreement (the "Purchase Agreement") with Piper Jaffray & Co. (the "Underwriter") relating to the issuance and sale (the "Offering") of 3,475,000 shares of Company Common Stock, par value $0.001 per share (the "Shares") at a per Share price of $7.25. Pursuant to the Purchase Agreement, the Company also granted the Underwriter the right to purchase an additional 521,250 shares within 30 days of January 16, 2013 to cover over-allotments, if any.

The Company estimates that it will receive net proceeds of approximately $23.4 million from the Offering after deducting underwriting discounts and commissions and offering expenses. The Company intends to use the net proceeds from the Offering for general corporate purposes and working capital. The Offering is subject to customary closing conditions and is expected to close on or about January 22, 2013.

The foregoing is only a brief description of the material terms of the Purchase Agreement and does not purport to be a complete description of the rights and obligations of the parties thereunder and is qualified in its entirety by reference to the Purchase Agreement, which is filed hereto as Exhibit 1.1 and incorporated by reference herein.

The legal opinion, including the related consent, of Keating Muething & Klekamp PLL relating to the issuance of the Shares is filed as Exhibit 5.1 to this Current Report on Form 8-K.

On January 15, 2013, we issued a press release announcing that we had commenced the Offering. On January 16, 2013, we issued a press release announcing that we had priced the Offering. The press releases are attached hereto as Exhibits 99.1 and 99.2, respectively.



Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No.       Description

1.1               Purchase Agreement dated January 16, 2013 by and between
                  AtriCure, Inc. and Piper Jaffray & Co.

5.1               Opinion of Keating Muething & Klekamp PLL.

23.1              Consent of Keating Muething & Klekamp PLL (included in Exhibit
                  5.1).

99.1              Press Release of AtriCure, Inc. dated January 15, 2013.

99.2              Press Release of AtriCure, Inc. dated January 16, 2013.


  Add ATRC to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for ATRC - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.